Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs Sevoflurane for Pediatric Ophthalmology Sedation
NCT05321160Completed
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Mar 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of esketamine in ophthalmologic disorders (2 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoints: Incidence of Emergence Agitation at 20 minutes, Incidence of Respiratory Depression at 1 hour and 5 more. Started Mar 2022; status: completed.
02
Drugs
esketamine
03
Conditions
ophthalmologic disorders
Beyond the preview
Go deeper on NCT05321160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05321160.